A study in humans demonstrated that hsa-miR-542-5p was significantly upregulated in the plasma of acute myocardial infarction patients compared to healthy controls, identifying it as a potential biomarker for MI [Baulina et al. DOI:10.1016/j.yjmcc.2018.07.129]. A separate review of human studies reported that hsa-miR-542-5p is upregulated in burn hypertrophic scar tissue versus normal skin and is also upregulated in venous ulcers compared to normal skin and acute wounds [Siu et al. DOI:10.1111/wrr.13100].